- 專業(yè)概況
- 所屬院系
- 中國(guó)學(xué)生入學(xué)要求
- 課程信息
專業(yè)概況
在這里學(xué)什么？
Overview
The Department of Molecular and Clinical Cancer Medicine is the centre for large European pancreas studies aimed at examining the benefit of chemotherapy and chemoradiotherapy in the treatment of patients who have undergone surgery to remove pancreas cancer tissue.
Pancreatology is one of Liverpool’s recognised strengths with scientific expertise in Pancreatic cancer and pancreatitis and strong clinical and science leadership.
Research themes
Our research themes include:
Clinical trials aimed at determining the overall benefits of current treatments and evaluating the benefits of newly emerging treatments for pancreatic cancer. The Division of Surgery and Oncology is the centre for large European pancreas studies including the ESPAC clinical trials aimed at examining the benefit of chemotherapy and chemoradiotherapy (the combined use of chemotherapy and radiotherapy) in the treatment of patients who have undergone surgery to remove pancreas cancer tissue. There are major clinical trials in advanced pancreatic cancer (such as Gem-Cap) and developmental trials focusing on new biological agents such as the use of targeted super-antibodies and gene therapy. In the palliative care setting we are at the forefront of assessing and optimising novel methods of symptom and pain control. These and other trials that are available to patients at Liverpool will hopefully improve our understanding of the currently available treatments for pancreas cancer
Development and Co-ordination of the world's largest collection of families with Hereditary Pancreatitis and Familial Pancreas Cancer. Researchers in the department are currently working with these families to identify the underlying genetic cause of cancer in patients where the disease is inherited. In young patients with Hereditary Pancreatitis and Idiopathic Pancreatitis we are trialling novel treatments to inhibit or minimize the frequency or severity of the attacks.
Our research interests
- Clinical studies conducted with the intent to advance therapies to the clinic or develop principles for application of therapeutics to human disease
- Non-human or non-clinical studies conducted with the intent to advance therapies to the clinic or develop principles for application of therapeutics to human disease
- Investigations in humans which define the biology of disease and provide the scientific foundation for the development of new or improved therapies for human disease
- Any clinical trial of a therapy that was initiated based on the above
- The biology-chemistry “bridge”.
所屬院系
進(jìn)入哪個(gè)院系學(xué)習(xí)？ Institute of Translational Medicine
中國(guó)學(xué)生入學(xué)要求
為來(lái)自中國(guó)的學(xué)生設(shè)計(jì) Students who do not meet the entry requirements stated above and students who hold a three-year diploma (Da Zhuan) from a recognised Chinese university with good grades, may be eligible for the University’s pre-Master's Programme delivered on campus at the University of Liverpool International College. Students need to have IELTS 6.5 overall with a minimum of 5.5 in each component.
課程信息
學(xué)制：全日制(2 年)
學(xué)費(fèi)：
開(kāi)學(xué)時(shí)間：2022九月13日
申請(qǐng)截止日期：
留學(xué)地點(diǎn)：University of LiverpoolThe Foundation Building,765 Brownlow Hill,Liverpool,L69 7ZX, England
院校相關(guān)閱讀
滬ICP備18048269號(hào)-1 
電子營(yíng)業(yè)執(zhí)照
教育
全國(guó)教育網(wǎng)站
企業(yè)信用等級(jí)AA級(jí)